Preoperative Cognitive Therapy for Improving Health Outcomes After TKA in High-risk Catastrophizing Subjects (CT_TKA)
Preoperative Cognitive Therapy for Improving Health Outcomes After Total Knee Replacement in High-risk Catastrophizing Subjects
Sponsor: Pfizer
A NA clinical study on Catastrophization, this trial is completed. The trial is conducted by Pfizer and has accumulated 10 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jul 2022 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
May 2021 — Jul 2022 [monthly]
Recruiting NA
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Recruiting NA
-
Nov 2020 — Dec 2020 [monthly]
Recruiting NA
-
May 2019 — Nov 2020 [monthly]
Recruiting NA
-
Jun 2018 — May 2019 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pfizer
- Rush University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .